Eyecelerator Conference to Take Place on Nov. 11 in New Orleans

Eyecelerator Conference to Take Place on Nov. 11 in New Orleans

October 19, 2021

Eyecelerator Conference is scheduled to take place on Thursday, November 11 at Ernest N. Morial Convention Center in New Orleans, U.S.

The Eyecelerator 2021 Conference series, a collaboration between the American Academy of Ophthalmology (AAO) and the American Society of Cataract and Refractive Surgery (ASCRS) is designed for all innovation stakeholders, including entrepreneurs, executives, investors, and ophthalmologists.

This year’s meeting is held in conjunction with the AAO’s annual meeting in New Orleans.

The Program Director is Gil Kliman, MD and co-chairs are Deepinder Dhaliwal, MD, L.Ac, Allen C. Ho, MD, and Thomas W. Samuelson, MD.

The conference will start at 8.05 a.m with a panel discussion under the theme of “2021 Advances in Ophthalmic Innovation: Clinical, Commercial, and Capital Markets”.

Leading experts from major global companies including Microsoft, Amazon, and Zeiss Medical Technology will talk about the impending impact of new technology on patient care, clinical data, and innovation​.

The panel discussion will be held under the name of “When, Where and How We'll See Big Successes in Digital Ophthalmology” between 8.30 and 9.15 a.m.

Between 9.15 to 10:00 a.m., Nazneen Aziz, Ph.D., Chief Scientific Officer, Avellino and Elizabeth Yeu, MD will try to find an answer to the question of “Will Cornea Transplantation Become Obsolete?”.

The topics to be mentioned in the panel discussion include: Treating Keratoconus and Endothelial Dystrophy in 2021 as well as the alternatives for Endothelial Keratoplasty.

Following the networking break, a session due to being held between 10:30 a.m to 11:15 a.m will shed light on “The Intersection of Reimbursement and Innovation”.

This session will forecast the impact on investment, innovation, patient care, and physician practice patterns from the perspective of practicing surgeons, industry leaders, and reimbursement experts.

Another panel session will cover “The Evolving Pathway to Creating Value for Patients in our Biomedical Ecosystem”. The guest speakers are Wiley Chambers, MD, Supervisory Medical Officer, Ophthalmology, FDA, and Reginald J. Sanders, MD.

Between 1:00 – 2:30 p.m., a diverse line-up of more than 30 companies, from startups to public, will present innovations at all stages in a unique, interactive format.

Showcases will include five-minute company presentations followed by a moderated Q+A with panels of seasoned strategics, investors, and KOLs. Audience members will also be invited to ask questions.

Separate breakout rooms will operate simultaneously for Retina vs. Anterior Segment companies that are then grouped by subsector and indication. 

The Conference will include a special segment for myopia and its prevention with the help of corrective lenses, drugs, and diagnostics.

Co-moderators Michael X. Repka, MD and Gil Kliman, MD, engage a panel of new category product innovators striving to mitigate the rapid global rise of myopia through early interventions.

A session named “What's Keeping Industry Leaders Up at Night?” promises a rare insider's look at the global business of ophthalmology from some of its most prominent leaders.

Avellino CEO Jim Mazzo will dig deep for insights about each company’s business strategy, examine how the industry is positioned to address key market needs, and even uncover which business challenges remain unsolved for these global strategics.

Following this, there will be 5 company presentations and Best of Show Award. The Conference will end by 6 p.m. after closing remarks and networking reception.